E-LIB Suche - Ergebnisse für: Suleymanova, Naida

1

Correction: IGF-1R is a molecular determinant for response ..:

Song, Dawei ; Cismas, Sonia ; Crudden, Caitrin...
Oncogene. , 2023

2

26653 Can β-arrestin isoforms control response of melanoma ..:

Girnita, Ada ; Crudden, Caitrin ; Suleymanova, Naida.
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB111 , 2021

Link: https://doi.org/10.1016/..

3

IGF-1R is a molecular determinant for response to p53 react..:

Song, Dawei ; Cismas, Sonia ; Crudden, Caitrin...
Oncogene. 41 (2021) 4 - p. 600-611 , 2021

Link: https://doi.org/10.1038/..

4

Enhanced response of melanoma cells to MEK inhibitors follo..:

Suleymanova, Naida ; Crudden, Caitrin ; Worrall, Claire...
Oncotarget. 8 (2017) 47 - p. 82256-82267 , 2017

Link: https://doi.org/10.18632..

5

The dichotomy of the Insulin-like growth factor 1 receptor:..:

Crudden, Caitrin ; Ilic, Marina ; Suleymanova, Naida...
Growth Hormone & IGF Research. 25 (2015) 1 - p. 2-12 , 2015

Link: https://doi.org/10.1016/..

6

Enhanced response of melanoma cells to MEK inhibitors follo..:

Suleymanova, Naida ; Crudden, Caitrin ; Worrall, Claire...
Suleymanova , N , Crudden , C , Worrall , C , Dricu , A , Girnita , A & Girnita , L 2017 , ' Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation ' , Oncotarget , vol. 8 , no. 47 , pp. 82256-82267 . https://doi.org/10.18632/oncotarget.19286. , 2017

Link: https://research.vumc.nl..

7

Beta-arrestins in cancer : linking pro-tumorigenic extracel..:

Suleymanova, Naida
I. Worrall C, Suleymanova N, Crudden C, Trocoli Drakensjö I, Candrea E, Nedelcu D, Takahashi S-I, Girnita L and Girnita A. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma Oncogene 2017 Jun 8;36(23):3274-3286; ::doi::10.1038/onc.2016.472 ::pmid::28092675 ::isi::000402869800007. , 2017

Link: http://hdl.handle.net/10..

8

Supplementary Figure 8 from Competing Engagement of β-arres..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709958.v1. , 2023

Link: https://doi.org/10.1158/..

9

Supplementary Figure 2 from Competing Engagement of β-arres..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709976.v1. , 2023

Link: https://doi.org/10.1158/..

10

Supplementary Figure 6 from Competing Engagement of β-arres..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709964.v1. , 2023

Link: https://doi.org/10.1158/..

11

Supplementary Figure 3 from Competing Engagement of β-arres..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709973.v1. , 2023

Link: https://doi.org/10.1158/..

12

Supplementary Figure 4 from Competing Engagement of β-arres..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709970.v1. , 2023

Link: https://doi.org/10.1158/..

13

Table S1 from Competing Engagement of β-arrestin Isoforms B..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709955.v1. , 2023

Link: https://doi.org/10.1158/..

14

Supplementary Figure 1 from Competing Engagement of β-arres..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709979.v1. , 2023

Link: https://doi.org/10.1158/..

15

Supplementary Figure 7 from Competing Engagement of β-arres..:

Sonia Cismas ; Sylvya Pasca ; Caitrin Crudden...
doi:10.1158/1541-7786.24709961.v1. , 2023

Link: https://doi.org/10.1158/..